The Discounted Cash Flow (DCF) valuation of TG Therapeutics Inc (TGTX) is (3.40) USD. With the latest stock price at 20.57 USD, the upside of TG Therapeutics Inc based on DCF is -116.5%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 6.7% - 8.9% | 7.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (6.42) - (2.53) | (3.40) |
| Upside | -131.2% - -112.3% | -116.5% |